|
1
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kushwah R and Hu J: Complexity of
dendritic cell subsets and their function in the host immune
system. Immunology. 133:409–419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schraml BU and e Sousa C Reis: Defining
dendritic cells. Curr Opin Immunol. 32:13–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guermonprez P, Valladeau J, Zitvogel L,
Théry C and Amigorena S: Antigen presentation and T cell
stimulation by dendritic cells. Annu Rev Immunol. 20:621–667. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lutz MB and Schuler G: Immature,
semi-mature and fully mature dendritic cells: Which signals induce
tolerance or immunity? Trends Immunol. 23:445–449. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Romani N, Gruner S, Brang D, Kampgen E,
Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM and
Schuler G: Proliferating dendritic cell progenitors in human blood.
J Exp Med. 180:83–93. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sallusto F and Lanzavecchia A: Efficient
presentation of soluble antigen by cultured human dendritic cells
is maintained by granulocyte/macrophage colony-stimulating factor
plus interleukin 4 and downregulated by tumor necrosis factor
alpha. J Exp Med. 179:1109–1118. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jonuleit H, Kühn U, Müller G, Steinbrink
K, Paragnik L, Schmitt E, Knop J and Enk AH: Pro-inflammatory
cytokines and prostaglandins induce maturation of potent
immunostimulatory dendritic cells under fetal calf serum-free
conditions. Eur J Immunol. 27:3135–3142. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng Z, Takahashi M, Narita M, Toba K,
Liu A, Furukawa T, Koike T and Aizawa Y: Generation of dendritic
cells from adherent cells of cord blood by culture with
granulocyte-macrophage colony-stimulating factor, interleukin-4,
and tumor necrosis factor-alpha. J Hematother Stem Cell Res.
9:453–464. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boullart AC, Aarntzen EH, Verdijk P,
Jacobs JF, Schuurhuis DH, Benitez-Ribas D, Schreibelt G, van de
Rakt MW, Scharenborg NM, de Boer A, et al: Maturation of
monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8
ligands combined with prostaglandin E2 results in high
interleukin-12 production and cell migration. Cancer Immunol
Immunother. 57:1589–1597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anguille S, Smits EL, Cools N, Goossens H,
Berneman ZN and Van Tendeloo VF: Short-term cultured,
interleukin-15 differentiated dendritic cells have potent
immunostimulatory properties. J Transl Med. 7:1092009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schuler-Thurner B, Schultz ES, Berger TG,
Weinlich G, Ebner S, Woerl P, Bender A, Feuerstein B, Fritsch PO,
Romani N and Schuler G: Rapid induction of tumor-specific type 1 T
helper cells in metastatic melanoma patients by vaccination with
mature, cryopreserved, peptide-loaded monocyte-derived dendritic
cells. J Exp Med. 195:1279–1288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu S, Koski GK, Faries M, Bedrosian I,
Mick R, Maeurer M, Cheever MA, Cohen PA and Czerniecki BJ: Rapid
high efficiency sensitization of CD8+ T cells to tumor antigens by
dendritic cells leads to enhanced functional avidity and direct
tumor recognition through an IL-12-dependent mechanism. J Immunol.
171:2251–2261. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ellebaek E, Engell-Noerregaard L, Iversen
TZ, Froesig TM, Munir S, Hadrup SR, Andersen MH and Svane IM:
Metastatic melanoma patients treated with dendritic cell
vaccination, Interleukin-2 and metronomic cyclophosphamide: Results
from a phase II trial. Cancer Immunol Immunother. 61:1791–1804.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC,
Due-Tønnesen P, Suso EM, Sæbøe-Larssen S, Sandberg C, Brinchmann
JE, Helseth E, et al: Therapeutic vaccination against autologous
cancer stem cells with mRNA-transfected dendritic cells in patients
with glioblastoma. Cancer Immunol Immunother. 62:1499–1509. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berntsen A, Trepiakas R, Wenandy L,
Geertsen PF, Straten P thor, Andersen MH, Pedersen AE, Claesson MH,
Lorentzen T, Johansen JS and Svane IM: Therapeutic dendritic cell
vaccination of patients with metastatic renal cell carcinoma: A
clinical phase 1/2 trial. J Immunother. 31:771–780. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lanzavecchia A and Sallusto F: Regulation
of T cell immunity by dendritic cells. Cell. 106:263–266. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mellman I: Dendritic cells: Master
regulators of the immune response. Cancer Immunol Res. 1:145–149.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leverkus M, Walczak H, McLellan A, Fries
HW, Terbeck G, Bröcker EB and Kämpgen E: Maturation of dendritic
cells leads to up-regulation of cellular FLICE-inhibitory protein
and concomitant down-regulation of death ligand-mediated apoptosis.
Blood. 96:2628–2631. 2000.PubMed/NCBI
|
|
20
|
Krause P, Singer E, Darley PI,
Klebensberger J, Groettrup M and Legler DF: Prostaglandin E2 is a
key factor for monocyte-derived dendritic cell maturation: Enhanced
T cell stimulatory capacity despite IDO. J Leukoc Biol.
82:1106–1114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Young JW and Steinman RM: Accessory cell
requirements for the mixed-leukocyte reaction and polyclonal
mitogens, as studied with a new technique for enriching blood
dendritic cells. Cell Immunol. 111:167–182. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Markowicz S and Engleman EG:
Granulocyte-macrophage colony-stimulating factor promotes
differentiation and survival of human peripheral blood dendritic
cells in vitro. J Clin Invest. 85:955–961. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Li J, Wu K, Azhati B and Rexiati
M: Culture and identification of mouse bone marrow-derived
dendritic cells and their capability to induce T lymphocyte
proliferation. Med Sci Monit. 22:244–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Draube A, Klein-González N, Mattheus S,
Brillant C, Hellmich M, Engert A and von Bergwelt-Baildon M:
Dendritic cell based tumor vaccination in prostate and renal cell
cancer: A systematic review and meta-analysis. PLoS One.
6:e188012011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
de Vries IJ, Lesterhuis WJ, Scharenborg
NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM,
Torensma R, Adema GJ, et al: Maturation of dendritic cells is a
prerequisite for inducing immune responses in advanced melanoma
patients. Clin Cancer Res. 9:5091–5100. 2003.PubMed/NCBI
|
|
26
|
Yamanaka R, Homma J, Yajima N, Tsuchiya N,
Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M and
Tanaka R: Clinical evaluation of dendritic cell vaccination for
patients with recurrent glioma: Results of a clinical phase I/II
trial. Clin Cancer Res. 11:4160–4167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anguille S, Smits EL, Lion E, van Tendeloo
VF and Berneman ZN: Clinical use of dendritic cells for cancer
therapy. Lancet Oncol. 15:e257–e267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cintolo JA, Datta J, Mathew SJ and
Czerniecki BJ: Dendritic cell-based vaccines: Barriers and
opportunities. Future Oncol. 8:1273–1299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greenwald RJ, Freeman GJ and Sharpe AH:
The B7 family revisited. Annu Rev Immunol. 23:515–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taraban VY, Rowley TF and Al-Shamkhani A:
Cutting edge: A critical role for CD70 in CD8 T cell priming by
CD40-licensed APCs. J Immunol. 173:6542–6546. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma DY and Clark EA: The role of CD40 and
CD154/CD40L in dendritic cells. Semin Immunol. 21:265–272. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Freeman GJ, Long AJ, Iwai Y, Bourque K,
Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne
MC, et al: Engagement of the PD-1 immunoinhibitory receptor by a
novel B7 family member leads to negative regulation of lymphocyte
activation. J Exp Med. 192:1027–1034. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carter L, Fouser LA, Jussif J, Fitz L,
Deng B, Wood CR, Collins M, Honjo T, Freeman GJ and Carreno BM:
PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells
and is overcome by IL-2. Eur J Immunol. 32:634–643. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Selenko-Gebauer N, Majdic O, Szekeres A,
Höfler G, Guthann E, Korthäuer U, Zlabinger G, Steinberger P, Pickl
WF, Stockinger H, et al: B7-H1 (programmed death-1 ligand) on
dendritic cells is involved in the induction and maintenance of T
cell anergy. J Immunol. 170:3637–3644. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trinchieri G: Interleukin-12 and the
regulation of innate resistance and adaptive immunity. Nat Rev
Immunol. 3:133–146. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Strioga MM, Felzmann T, Powell DJ Jr,
Ostapenko V, Dobrovolskiene NT, Matuskova M, Michalek J and Schijns
VE: Therapeutic dendritic cell-based cancer vaccines: The state of
the art. Crit Rev Immunol. 33:489–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Carreno BM, Becker-Hapak M, Huang A, Chan
M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM and
Linette GP: IL-12p70-producing patient DC vaccine elicits
Tc1-polarized immunity. J Clin Invest. 123:3383–3394. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okada H, Kalinski P, Ueda R, Hoji A,
Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK,
et al: Induction of CD8+ T-cell responses against novel
glioma-associated antigen peptides and clinical activity by
vaccinations with {alpha}-type 1 polarized dendritic cells and
polyinosinic-polycytidylic acid stabilized by lysine and
carboxymethylcellulose in patients with recurrent malignant glioma.
J Clin Oncol. 29:330–336. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee AW, Truong T, Bickham K, Fonteneau JF,
Larsson M, Da Silva I, Somersan S, Thomas EK and Bhardwaj N: A
clinical grade cocktail of cytokines and PGE2 results in uniform
maturation of human monocyte-derived dendritic cells: Implications
for immunotherapy. Vaccine. 20 Suppl 4:A8–A22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Trepiakas R, Pedersen AE, Met O, Hansen
MH, Berntsen A and Svane IM: Comparison of alpha-Type-1 polarizing
and standard dendritic cell cytokine cocktail for maturation of
therapeutic monocyte-derived dendritic cell preparations from
cancer patients. Vaccine. 26:2824–2832. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fiorentino DF, Bond MW and Mosmann TR: Two
types of mouse T helper cell. IV. Th2 clones secrete a factor that
inhibits cytokine production by Th1 clones. J Exp Med.
170:2081–2095. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Couper KN, Blount DG and Riley EM: IL-10:
The master regulator of immunity to infection. J Immunol.
180:5771–5777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mittal SK and Roche PA: Suppression of
antigen presentation by IL-10. Curr Opin Immunol. 34:22–27. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song S, Wang Y, Wang J, Lian W, Liu S,
Zhang Z, Liu F and Wei L: Tumour-derived IL-10 within tumour
microenvironment represses the antitumour immunity of
Socs1-silenced and sustained antigen expressing DCs. Eur J Cancer.
48:2252–2259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vassiliou E, Sharma V, Jing H, Sheibanie F
and Ganea D: Prostaglandin E2 promotes the survival of bone
marrow-derived dendritic cells. J Immunol. 173:6955–6964. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Baratelli F, Krysan K, Heuzé-Vourc'h N,
Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M and Dubinett
SM: PGE2 confers survivin-dependent apoptosis resistance in human
monocyte-derived dendritic cells. J Leukoc Biol. 78:555–564. 2005.
View Article : Google Scholar : PubMed/NCBI
|
